FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114962014> ?p ?o ?g. }

• W2114962014 endingPage "1136" @default.
• W2114962014 startingPage "1129" @default.
• W2114962014 abstract "Objective:The objective of this analysis was to compare costs of paricalcitol or cinacalcet plus low dose vitamin D, and of phosphate binders, in patients in the IMPACT SHPT study; and to extrapolate those to estimate expected annual maintenance costs.Methods:IMPACT SHPT was a 28-week, randomized, open-label trial. Subjects from 12 countries received intravenous (IV) or oral paricalcitol, or oral cinacalcet plus fixed IV doxercalciferol or oral alfacalcidol. The primary end-point was the proportion of subjects who achieved a mean intact parathyroid hormone (iPTH) value of 150–300 pg/mL during weeks 21–28 (evaluation period). This study compares the costs of study drugs and phosphate binders among participants during the study and annualized. This analysis includes only those subjects that reached the evaluation period (134 in each group).Results:The mean total drug costs over the study period were €2606 (SD = €2000) in the paricalcitol group and €3034 (SD = €3006) in the cinacalcet group (difference €428, p = 0.1712). The estimated annualized costs were €5387 (SD = €4139) in the paricalcitol group and €6870 (SD = €6256) in the cinacalcet group (difference €1492, p = 0.0395). In addition, a significantly greater proportion (p = 0.010) of subjects in the paricalcitol arm (56.0%) achieved an iPTH of 150–300 pg/mL during the evaluation period compared to the cinacalcet arm (38.2%).Limitations:This was a secondary analysis of the IMPACT SHPT study which was not designed or powered for costs as an outcome. The dosing of study drugs and phosphate binders in the IMPACT study may not reflect actual practice, and patients were followed for 28 weeks, while the treatment of SHPT is long-term.Conclusion:Patients with SHPT requiring hemodialysis who were treated with a paricalcitol-based regimen for iPTH control had lower estimated annual drug costs compared to those treated with cinacalcet plus low-dose vitamin D." @default.
• W2114962014 created "2016-06-24" @default.
• W2114962014 creator A5032326673 @default.
• W2114962014 creator A5043774040 @default.
• W2114962014 creator A5046643853 @default.
• W2114962014 creator A5067357053 @default.
• W2114962014 creator A5091576969 @default.
• W2114962014 date "2013-07-24" @default.
• W2114962014 modified "2023-09-23" @default.
• W2114962014 title "Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients" @default.
• W2114962014 cites W1967906144 @default.
• W2114962014 cites W1973835767 @default.
• W2114962014 cites W1983133134 @default.
• W2114962014 cites W1996387976 @default.
• W2114962014 cites W1997341767 @default.
• W2114962014 cites W2007947358 @default.
• W2114962014 cites W2017015351 @default.
• W2114962014 cites W2022709430 @default.
• W2114962014 cites W2023637811 @default.
• W2114962014 cites W2026322740 @default.
• W2114962014 cites W2035017607 @default.
• W2114962014 cites W2036419389 @default.
• W2114962014 cites W2036513662 @default.
• W2114962014 cites W2041692221 @default.
• W2114962014 cites W2045516356 @default.
• W2114962014 cites W2081567621 @default.
• W2114962014 cites W2086549975 @default.
• W2114962014 cites W2087806333 @default.
• W2114962014 cites W2099422638 @default.
• W2114962014 cites W2105417592 @default.
• W2114962014 cites W2135402159 @default.
• W2114962014 cites W2136486000 @default.
• W2114962014 cites W2143664225 @default.
• W2114962014 cites W2144627797 @default.
• W2114962014 cites W2145632027 @default.
• W2114962014 cites W2163182278 @default.
• W2114962014 cites W2164919062 @default.
• W2114962014 cites W2548549197 @default.
• W2114962014 doi "https://doi.org/10.3111/13696998.2013.823092" @default.
• W2114962014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23834479" @default.
• W2114962014 hasPublicationYear "2013" @default.
• W2114962014 type Work @default.
• W2114962014 sameAs 2114962014 @default.
• W2114962014 citedByCount "4" @default.
• W2114962014 countsByYear W21149620142013 @default.
• W2114962014 countsByYear W21149620142016 @default.
• W2114962014 countsByYear W21149620142019 @default.
• W2114962014 countsByYear W21149620142021 @default.
• W2114962014 crossrefType "journal-article" @default.
• W2114962014 hasAuthorship W2114962014A5032326673 @default.
• W2114962014 hasAuthorship W2114962014A5043774040 @default.
• W2114962014 hasAuthorship W2114962014A5046643853 @default.
• W2114962014 hasAuthorship W2114962014A5067357053 @default.
• W2114962014 hasAuthorship W2114962014A5091576969 @default.
• W2114962014 hasBestOaLocation W21149620141 @default.
• W2114962014 hasConcept C124490489 @default.
• W2114962014 hasConcept C126322002 @default.
• W2114962014 hasConcept C126894567 @default.
• W2114962014 hasConcept C141071460 @default.
• W2114962014 hasConcept C2775945674 @default.
• W2114962014 hasConcept C2776036575 @default.
• W2114962014 hasConcept C2776541429 @default.
• W2114962014 hasConcept C2776886416 @default.
• W2114962014 hasConcept C2777425297 @default.
• W2114962014 hasConcept C2778063415 @default.
• W2114962014 hasConcept C2778838027 @default.
• W2114962014 hasConcept C2779126354 @default.
• W2114962014 hasConcept C2779524405 @default.
• W2114962014 hasConcept C2780534505 @default.
• W2114962014 hasConcept C2781208988 @default.
• W2114962014 hasConcept C519063684 @default.
• W2114962014 hasConcept C71924100 @default.
• W2114962014 hasConceptScore W2114962014C124490489 @default.
• W2114962014 hasConceptScore W2114962014C126322002 @default.
• W2114962014 hasConceptScore W2114962014C126894567 @default.
• W2114962014 hasConceptScore W2114962014C141071460 @default.
• W2114962014 hasConceptScore W2114962014C2775945674 @default.
• W2114962014 hasConceptScore W2114962014C2776036575 @default.
• W2114962014 hasConceptScore W2114962014C2776541429 @default.
• W2114962014 hasConceptScore W2114962014C2776886416 @default.
• W2114962014 hasConceptScore W2114962014C2777425297 @default.
• W2114962014 hasConceptScore W2114962014C2778063415 @default.
• W2114962014 hasConceptScore W2114962014C2778838027 @default.
• W2114962014 hasConceptScore W2114962014C2779126354 @default.
• W2114962014 hasConceptScore W2114962014C2779524405 @default.
• W2114962014 hasConceptScore W2114962014C2780534505 @default.
• W2114962014 hasConceptScore W2114962014C2781208988 @default.
• W2114962014 hasConceptScore W2114962014C519063684 @default.
• W2114962014 hasConceptScore W2114962014C71924100 @default.
• W2114962014 hasIssue "9" @default.
• W2114962014 hasLocation W21149620141 @default.
• W2114962014 hasLocation W21149620142 @default.
• W2114962014 hasOpenAccess W2114962014 @default.
• W2114962014 hasPrimaryLocation W21149620141 @default.
• W2114962014 hasRelatedWork W1526873178 @default.
• W2114962014 hasRelatedWork W1989621771 @default.
• W2114962014 hasRelatedWork W1996609898 @default.
• W2114962014 hasRelatedWork W2064190145 @default.

• next